<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en"><head>  
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=994, user-scalable=yes"> 
  <meta http-equiv="content-type" content="text/html; charset=UTF-8">
    <meta name="robots" content="noindex,nofollow">
    <title>Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial - Full Text View - ClinicalTrials.gov</title>
    <link href="https://clinicaltrials.gov/ct2/show/NCT00041938" rel="canonical">
  
  <link rel="shortcut icon" href="https://clinicaltrials.gov/ct2/html/images/favicon.ico">
	<link rel="apple-touch-icon-precomposed" href="https://clinicaltrials.gov/apple-touch-icon-144x144.png" sizes="144x144">
	<link rel="apple-touch-icon-precomposed" href="https://clinicaltrials.gov/apple-touch-icon-114x114.png" sizes="114x114">
	<link rel="apple-touch-icon-precomposed" href="https://clinicaltrials.gov/apple-touch-icon-72x72.png" sizes="72x72">
	<link rel="apple-touch-icon-precomposed" href="https://clinicaltrials.gov/apple-touch-icon-precomposed.png">
	<link rel="apple-touch-icon-precomposed" href="https://clinicaltrials.gov/apple-touch-icon.png">

  <link rel="stylesheet" type="text/css" href="Warfarin%20Versus%20Aspirin%20in%20Reduced%20Cardiac%20Ejection%20Fraction%20%28WARCEF%29%20Trial%20-%20Full%20Text%20View%20-%20ClinicalTrials.gov_files/superfish.css" media="screen">
  <link href="Warfarin%20Versus%20Aspirin%20in%20Reduced%20Cardiac%20Ejection%20Fraction%20%28WARCEF%29%20Trial%20-%20Full%20Text%20View%20-%20ClinicalTrials.gov_files/base.css" rel="stylesheet" type="text/css">

	<link rel="stylesheet" href="Warfarin%20Versus%20Aspirin%20in%20Reduced%20Cardiac%20Ejection%20Fraction%20%28WARCEF%29%20Trial%20-%20Full%20Text%20View%20-%20ClinicalTrials.gov_files/print.css" type="text/css" media="print">
	
	

     <!--[if lte IE 7]>
           <link href="/ct2/html/ct3/css/target-IE7-and-below.css" rel="stylesheet" type="text/css">
    <![endif]-->

<link href="Warfarin%20Versus%20Aspirin%20in%20Reduced%20Cardiac%20Ejection%20Fraction%20%28WARCEF%29%20Trial%20-%20Full%20Text%20View%20-%20ClinicalTrials.gov_files/trial-record.css" rel="stylesheet" type="text/css">
<link href="Warfarin%20Versus%20Aspirin%20in%20Reduced%20Cardiac%20Ejection%20Fraction%20%28WARCEF%29%20Trial%20-%20Full%20Text%20View%20-%20ClinicalTrials.gov_files/ct2Header.css" rel="stylesheet" type="text/css">


    <script type="text/javascript" src="Warfarin%20Versus%20Aspirin%20in%20Reduced%20Cardiac%20Ejection%20Fraction%20%28WARCEF%29%20Trial%20-%20Full%20Text%20View%20-%20ClinicalTrials.gov_files/jquery-1.js"></script>
    <script type="text/javascript" src="Warfarin%20Versus%20Aspirin%20in%20Reduced%20Cardiac%20Ejection%20Fraction%20%28WARCEF%29%20Trial%20-%20Full%20Text%20View%20-%20ClinicalTrials.gov_files/superfish.js"></script>
    <script type="text/javascript" src="Warfarin%20Versus%20Aspirin%20in%20Reduced%20Cardiac%20Ejection%20Fraction%20%28WARCEF%29%20Trial%20-%20Full%20Text%20View%20-%20ClinicalTrials.gov_files/supersubs.js"></script>
    <script type="text/javascript" src="Warfarin%20Versus%20Aspirin%20in%20Reduced%20Cardiac%20Ejection%20Fraction%20%28WARCEF%29%20Trial%20-%20Full%20Text%20View%20-%20ClinicalTrials.gov_files/hoverIntent.js"></script>
    <script type="text/javascript" src="Warfarin%20Versus%20Aspirin%20in%20Reduced%20Cardiac%20Ejection%20Fraction%20%28WARCEF%29%20Trial%20-%20Full%20Text%20View%20-%20ClinicalTrials.gov_files/jquery.js"></script>
    <script type="text/javascript" src="Warfarin%20Versus%20Aspirin%20in%20Reduced%20Cardiac%20Ejection%20Fraction%20%28WARCEF%29%20Trial%20-%20Full%20Text%20View%20-%20ClinicalTrials.gov_files/jquery_002.js"></script>

    <script type="text/javascript" src="Warfarin%20Versus%20Aspirin%20in%20Reduced%20Cardiac%20Ejection%20Fraction%20%28WARCEF%29%20Trial%20-%20Full%20Text%20View%20-%20ClinicalTrials.gov_files/ct.js"></script>
    <script type="text/javascript" src="Warfarin%20Versus%20Aspirin%20in%20Reduced%20Cardiac%20Ejection%20Fraction%20%28WARCEF%29%20Trial%20-%20Full%20Text%20View%20-%20ClinicalTrials.gov_files/ctmenu.js"></script>

    <script type="text/javascript" src="Warfarin%20Versus%20Aspirin%20in%20Reduced%20Cardiac%20Ejection%20Fraction%20%28WARCEF%29%20Trial%20-%20Full%20Text%20View%20-%20ClinicalTrials.gov_files/foresee-trigger.js"></script>
<script type="text/javascript">
    $(window).load(function(){
        loadCTCommon();
        });
</script>


  <script type="text/javascript">
    ncbi_pingWithImage = true;
    ncbi_generateSid = true;
    ncbi_signinUrl = "//www.ncbi.nlm.nih.gov/portal/signin.fcgi?cmd=Nop";
    __ncbi_stat_url="//www.ncbi.nlm.nih.gov/stat";        
  </script>
  
  <meta name="ncbi_app" content="ctgov">
  <meta name="ncbi_db" content="ctgov">
  <meta name="ncbi_pdid" content="show_study">
  <meta name="ncbi_pcid" content="NCT00041938">
  <meta name="ncbi_ctreqid" content="RboAAMq4">
  <meta name="ncbi_ctsessid" content="SboAAJNf">
  <meta name="ncbi_ctipid" content="IMuu1jj2">
  <meta name="ncbi_cthost" content="wp2">
  <meta name="ncbi_ctterm" content="&quot;Heart attack&quot; AND &quot;Los Angeles&quot;">
  <meta name="ncbi_ctrank" content="5">
  
<style media="print" type="text/css">.print-log { position:absolute;left:-10000px;top:auto;width:1px;height:1px;overflow:hidden; }.print-log li { list-style-image: url('/stat?jsevent=print&ncbi_app=ctgov&ncbi_db=ctgov&ncbi_pcid=NCT00041938&ncbi_pdid=show_study'); }</style><style type="text/css">.print-log { position:absolute;left:-10000px;top:auto;width:1px;height:1px;overflow:hidden; }</style><script src="Warfarin%20Versus%20Aspirin%20in%20Reduced%20Cardiac%20Ejection%20Fraction%20%28WARCEF%29%20Trial%20-%20Full%20Text%20View%20-%20ClinicalTrials.gov_files/foresee-surveydef.js" type="text/javascript"></script></head>

<body class="js one-column"> 
<div id="skip"> <a href="#main-content">Skip to Main Content</a> </div>

<div id="wrapper">  
  
	<div id="header"> <a href="https://clinicaltrials.gov/ct2/home" style="border: none;"><img src="Warfarin%20Versus%20Aspirin%20in%20Reduced%20Cardiac%20Ejection%20Fraction%20%28WARCEF%29%20Trial%20-%20Full%20Text%20View%20-%20ClinicalTrials.gov_files/ct.png" alt="ClinicalTrials.gov" height="33" width="248"></a><br>
    <div id="tagline">A service of the U.S. National Institutes of Health</div>
		 
<div id="header-search">
	<p class="for-example">Example: "Heart attack" AND "Los Angeles"</p>
	<form method="get" action="/ct2/results" onsubmit="sendSearchPing(); return true;">
	<label for="header-search-query">Search for studies:</label>
	<div><input id="header-search-query" name="term" size="43" maxlength="250" type="text"></div>
	<div><input name="Search" value="Search" type="submit"></div>
	
</form>
	<div id="header-search-extras">
			<ul>
				<li class="first-item"><a href="https://clinicaltrials.gov/ct2/search/advanced">Advanced Search</a></li>
				<li><a href="https://clinicaltrials.gov/ct2/help/how-find/basic">Help</a></li>
				<li><a href="https://clinicaltrials.gov/ct2/search/browse?brwse=cond_cat">Studies by Topic</a></li>
				<li class="last-item"><a href="https://clinicaltrials.gov/ct2/about-studies/glossary">Glossary</a></li>
			</ul>
	</div>
</div>
   </div>



	<div id="global-nav">
		<ul class="sf-menu sf-js-enabled sf-shadow">
			<li class="first"><a class="sf-with-ul" href="https://clinicaltrials.gov/ct2/search/index">Find Studies<span class="sf-sub-indicator"> »</span></a>
			<ul style="float: none; width: 21.1429em; display: none; visibility: hidden;">
                      <li style="white-space: normal; float: left; width: 100%;"><a style="float: none; width: auto;" href="https://clinicaltrials.gov/ct2/search">Basic Search</a></li>
                      <li style="white-space: normal; float: left; width: 100%;"><a style="float: none; width: auto;" href="https://clinicaltrials.gov/ct2/search/advanced">Advanced Search</a></li>
                      <li style="white-space: normal; float: left; width: 100%;"><a style="float: none; width: auto;" href="https://clinicaltrials.gov/ct2/search/browse?brwse=cond_cat">See Studies by Topic</a></li>
                      <li style="white-space: normal; float: left; width: 100%;"><a style="float: none; width: auto;" href="https://clinicaltrials.gov/ct2/search/map">See Studies on Map</a></li>
                      <li style="white-space: normal; float: left; width: 100%;" class="new-group"><a style="float: none; width: auto;" href="https://clinicaltrials.gov/ct2/help/how-find/index">How to Search</a></li>
                      <li style="white-space: normal; float: left; width: 100%;"><a style="float: none; width: auto;" href="https://clinicaltrials.gov/ct2/help/how-use-search-results">How to Use Search Results</a></li>
                      <li style="white-space: normal; float: left; width: 100%;"><a style="float: none; width: auto;" href="https://clinicaltrials.gov/ct2/help/how-find/find-study-results">How to Find Results of Studies</a></li>
                      <li style="white-space: normal; float: left; width: 100%;"><a style="float: none; width: auto;" href="https://clinicaltrials.gov/ct2/help/how-read-study">How to Read a Study Record</a></li>
			</ul>
			</li>
			<li><a class="sf-with-ul" href="https://clinicaltrials.gov/ct2/about-studies">About Clinical Studies<span class="sf-sub-indicator"> »</span></a>
			<ul style="float: none; width: 21.1429em; display: none; visibility: hidden;">
                      <li style="white-space: normal; float: left; width: 100%;"><a style="float: none; width: auto;" href="https://clinicaltrials.gov/ct2/about-studies/learn">Learn About Clinical Studies</a></li>
                      <li style="white-space: normal; float: left; width: 100%;"><a style="float: none; width: auto;" href="https://clinicaltrials.gov/ct2/about-studies/other-sites">Other Sites About Clinical Studies</a></li>
                      <li style="white-space: normal; float: left; width: 100%;"><a style="float: none; width: auto;" href="https://clinicaltrials.gov/ct2/about-studies/glossary">Glossary of Common Site Terms</a></li>
			</ul>
			</li>
			<li><a class="sf-with-ul" href="https://clinicaltrials.gov/ct2/manage-recs">Submit Studies<span class="sf-sub-indicator"> »</span></a>
			<ul style="float: none; width: 23.0714em; display: none; visibility: hidden;">
                      <li style="white-space: normal; float: left; width: 100%;"><a style="float: none; width: auto;" href="https://clinicaltrials.gov/ct2/manage-recs/background">Why Should I Register and Submit Results?</a></li>
                      <li style="white-space: normal; float: left; width: 100%;"><a style="float: none; width: auto;" href="https://clinicaltrials.gov/ct2/manage-recs/fdaaa">FDAAA 801 Requirements</a></li>
                      <li style="white-space: normal; float: left; width: 100%;" class="new-group"><a style="float: none; width: auto;" href="https://clinicaltrials.gov/ct2/manage-recs/how-apply">How to Apply for an Account</a></li>
                      <li style="white-space: normal; float: left; width: 100%;"><a style="float: none; width: auto;" href="https://clinicaltrials.gov/ct2/manage-recs/how-register">How to Register Your Study</a></li>
                      <li style="white-space: normal; float: left; width: 100%;"><a style="float: none; width: auto;" href="https://clinicaltrials.gov/ct2/manage-recs/how-edit">How to Edit Your Study Record</a></li>
                      <li style="white-space: normal; float: left; width: 100%;"><a style="float: none; width: auto;" href="https://clinicaltrials.gov/ct2/manage-recs/how-report">How to Submit Your Results</a></li>
                      <li style="white-space: normal; float: left; width: 100%;" class="new-group"><a style="float: none; width: auto;" href="https://clinicaltrials.gov/ct2/manage-recs/faq">Frequently Asked Questions</a></li>
                      <li style="white-space: normal; float: left; width: 100%;"><a style="float: none; width: auto;" href="https://clinicaltrials.gov/ct2/manage-recs/resources">Support Materials</a></li>
                      <li style="white-space: normal; float: left; width: 100%;"><a style="float: none; width: auto;" href="https://clinicaltrials.gov/ct2/manage-recs/present">Training Materials</a></li>
			</ul>
			</li>
			<li><a class="sf-with-ul" href="https://clinicaltrials.gov/ct2/resources">Resources<span class="sf-sub-indicator"> »</span></a>
			<ul style="float: none; width: 21.1429em; display: none; visibility: hidden;">
                      <li style="white-space: normal; float: left; width: 100%;"><a style="float: none; width: auto;" href="https://clinicaltrials.gov/ct2/resources/pubs">Selected Publications</a></li>
                      <li style="white-space: normal; float: left; width: 100%;"><a style="float: none; width: auto;" href="https://clinicaltrials.gov/ct2/resources/alert">Clinical Alerts and Advisories</a></li>
                      <li style="white-space: normal; float: left; width: 100%;"><a style="float: none; width: auto;" href="https://clinicaltrials.gov/ct2/resources/rss">RSS Feeds</a></li>
                      <li style="white-space: normal; float: left; width: 100%;" class="new-group"><a style="float: none; width: auto;" href="https://clinicaltrials.gov/ct2/resources/trends">Trends, Charts, and Maps</a></li>
                      <li style="white-space: normal; float: left; width: 100%;"><a style="float: none; width: auto;" href="https://clinicaltrials.gov/ct2/resources/download">Downloading Content for Analysis</a></li>
			</ul>
			</li>
			<li class="last"><a class="sf-with-ul" href="https://clinicaltrials.gov/ct2/about-site">About This Site<span class="sf-sub-indicator"> »</span></a>
			<ul style="float: none; width: 21.1429em; display: none; visibility: hidden;">
                      <li style="white-space: normal; float: left; width: 100%;"><a style="float: none; width: auto;" href="https://clinicaltrials.gov/ct2/about-site/background">ClinicalTrials.gov Background</a></li>
                      <li style="white-space: normal; float: left; width: 100%;"><a style="float: none; width: auto;" href="https://clinicaltrials.gov/ct2/about-site/results">About the Results Database</a></li>
                      <li style="white-space: normal; float: left; width: 100%;"><a style="float: none; width: auto;" href="https://clinicaltrials.gov/ct2/about-site/history">History, Policies, and Laws</a></li>
                      <li style="white-space: normal; float: left; width: 100%;"><a style="float: none; width: auto;" href="https://clinicaltrials.gov/ct2/about-site/for-media">Media/Press Resources</a></li>
                      <li style="white-space: normal; float: left; width: 100%;" class="new-group"><a style="float: none; width: auto;" href="https://clinicaltrials.gov/ct2/about-site/link-to">Linking to This Site</a></li>
                      <li style="white-space: normal; float: left; width: 100%;"><a style="float: none; width: auto;" href="https://clinicaltrials.gov/ct2/about-site/terms-conditions">Terms and Conditions</a></li>
                      <li style="white-space: normal; float: left; width: 100%;"><a style="float: none; width: auto;" href="https://clinicaltrials.gov/ct2/about-site/disclaimer">Disclaimer</a></li>
			</ul>
			</li>
		</ul>
    <div style="clear:both;"></div>
  </div>


<div id="utilities">
            <div id="text-size"> <a class="show-arrow" id="show-dropdown" href="https://clinicaltrials.gov/ct2/textsize-help"><span>Text Size</span></a>
               <ul style="display: none;" id="dropdown">
                <li><a href="#" id="up">Make bigger</a></li>
                <li><a href="#" id="down">Make smaller</a></li>
                <li><a href="#" id="reset">Reset</a></li>
                <li class="close"><a href="#" id="close">close</a></li>
            </ul>
           </div>

</div>
<div id="breadcrumb">
	<ul class="horz-list">
		<li><a href="https://clinicaltrials.gov/ct2/home">Home</a></li>

		<li><a href="https://clinicaltrials.gov/ct2/search">Find Studies</a></li>
		<li><a href="https://clinicaltrials.gov/ct2/results?term=%22Heart+attack%22+AND+%22Los+Angeles%22&amp;pg=1">Search Results</a></li>		<li class="last">Study Record Detail</li>
	</ul>
</div>


<div id="main-content" tabindex="-1">



        	<div id="search-results">
		<div class="results-summary">Trial record <strong>5 of 148</strong> for:
        &nbsp;&nbsp; "Heart attack" AND "Los Angeles"
        </div>
        <div class="results-nav">
        <a href="https://clinicaltrials.gov/ct2/show/study?term=%22Heart+attack%22+AND+%22Los+Angeles%22&amp;rank=4" class="prev-link">Previous Study</a>         | <a href="https://clinicaltrials.gov/ct2/results?term=%22Heart+attack%22+AND+%22Los+Angeles%22&amp;pg=1" class="return-link">Return to List</a> |
         <a href="https://clinicaltrials.gov/ct2/show/study?term=%22Heart+attack%22+AND+%22Los+Angeles%22&amp;rank=6" class="next-link">Next Study</a> 		</div>
	</div>
	<h1>Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial</h1>
	<div id="trial-info-1" class="floater-50">

     


      
        <div class="not-recruiting-status">
      This study has been completed.
          </div>
        
        
      
        




                <div class="info-title">Sponsor:</div>
                <div class="info-text" id="sponsor"> Columbia University </div>


                <div class="info-title">Collaborator:</div>
                 				   <div class="info-text">National Institute of Neurological Disorders and Stroke (NINDS)</div> 				
                <div class="info-title">Information provided by (Responsible Party):</div>
                <div class="info-text">Shunichi Homma, Columbia University</div>


            </div>
               <div id="trial-info-2" class="floater-50">
                <div class="info-title">ClinicalTrials.gov Identifier:</div>
                <div class="identifier">NCT00041938</div>
                <div class="info-date">First received: July 19, 2002</div>
                <div class="info-date">Last updated:  August 29, 2014</div>
                <div class="info-date">Last verified:  August 2014 </div>
                <div class="info-date"> <a href="https://clinicaltrials.gov/ct2/archive/NCT00041938" title="Historical versions of study NCT00041938 on ClinicalTrials.gov Archive Site - opens in new window" onclick="openNewWindow('/ct2/archive/NCT00041938'); return false;">History of Changes</a> </div>
            </div>



<div id="tabs">
        <ul id="tab-links">
			<li id="full-text" class="current color-bullet"><span class="li-content">Full Text View     </span></li>
			<li class="color-bullet" id="tabular"><span class="li-content"><a href="https://clinicaltrials.gov/ct2/show/record/NCT00041938?term=%22Heart+attack%22+AND+%22Los+Angeles%22&amp;rank=5">Tabular View</a></span></li>
			<li class="color-bullet" id="results"><span class="li-content"><a href="https://clinicaltrials.gov/ct2/show/results/NCT00041938?term=%22Heart+attack%22+AND+%22Los+Angeles%22&amp;rank=5">Study Results</a></span></li>
			<li class="color-bullet" id="disclaimer"><span class="li-content"><a href="https://clinicaltrials.gov/ct2/about-site/disclaimer">Disclaimer</a></span></li>
			<li class="color-bullet" id="howtoread"><span class="li-content"><a title="How to Read a Study Record - opens new window" href="https://clinicaltrials.gov/ct2/help/how-read-study" onclick="openNewWindow('/ct2/help/how-read-study'); return false">How to Read a Study Record</a></span></li>
        </ul>
</div>  




  
<!-- purpose_section -->
<div class="indent1" style="margin-top:3ex">
<img src="Warfarin%20Versus%20Aspirin%20in%20Reduced%20Cardiac%20Ejection%20Fraction%20%28WARCEF%29%20Trial%20-%20Full%20Text%20View%20-%20ClinicalTrials.gov_files/triangle.gif" alt=""><span class="header2">&nbsp; Purpose</span>

<div class="indent2" style="margin-top:2ex">

  <div class="body3"><p style="margin-top:0ex; margin-bottom:1ex;">The 
purpose of this study is to determine which of two treatments, Warfarin 
or aspirin, is better for preventing death and stroke in patients with 
poor heart function.</p>
    <p style="margin-top:0ex; margin-bottom:1ex;">We are now transitioning into the sub-analysis part of the WARCEF patient data.</p>
    <p style="margin-top:0ex; margin-bottom:1ex;">The study has recently
 completed data analysis for its Primary Aim. All randomized patients 
have completed their follow up. All study related procedure as per the 
protocol has been completed. We are now in the extension phase of the 
study to obtain more patient data to address further aims of the study. 
No new procedures are performed and data already in place at the sites 
will be collected (EKG and echocardiograms).</p>
    <p style="margin-top:0ex; margin-bottom:1ex;">The aims for this study extension are:</p>
    <ul style="margin-top:1ex; margin-bottom:1ex;">
      <li class="color-bullet" style="margin-top:0.7ex;"><span class="li-content">To assess progression of cardiac dysfunction over time among heart failure patients</span></li>
      <li class="color-bullet" style="margin-top:0.7ex;"><span class="li-content">To correlate prognosis with cardiac dysfunction</span></li>
    </ul></div><br>

    <!-- condition, intervention, phase summary table -->
  <div align="center">
  <table class="data_table" border="1" cellpadding="5" cellspacing="0" width="80%">
    <tbody><tr align="left">
            <th class="header3 pale_banner_color">
        <a class="study-link" href="https://clinicaltrials.gov/ct2/help/conditions_desc" title="Help on Conditions field" onclick="openPopupWindow('/ct2/help/conditions_desc',false); return false;">Condition</a>
      </th>
                  <th class="header3 pale_banner_color">
        <a class="study-link" href="https://clinicaltrials.gov/ct2/help/interventions_desc" title="Help on Interventions field" onclick="openPopupWindow('/ct2/help/interventions_desc',false); return false;">Intervention</a>
      </th>
                  <th class="header3 pale_banner_color">
        <a class="study-link" href="https://clinicaltrials.gov/ct2/help/phase_desc" title="Help on Phase field" onclick="openPopupWindow('/ct2/help/phase_desc',false); return false;">Phase</a>
      </th>
          </tr>
    <tr align="left" valign="top">
            <td class="body3" nowrap="nowrap">
                Heart Disease<br>
                Stroke<br>
                Ischemic Heart Disease<br>
                <span class="hit_syn">Myocardial Infarction</span><br>
              </td>
                  <td class="body3" nowrap="nowrap">
                Drug: aspirin<br>
                Drug: Warfarin<br>
              </td>
                  <td class="body3" nowrap="nowrap">
                Phase 3<br>
              </td>
          </tr>
  </tbody></table>
  </div>
  <br>
  
  
  <table summary="Layout table for study information" class="layout_table" style="margin-bottom:2ex;" border="0" cellpadding="0" cellspacing="0">
    <thead>
    <tr>
      <th id="studyInfoColTitle" style="display:none"></th>
      <th id="studyInfoColData" style="display:none"></th>
    </tr>
    </thead>
        <tbody><tr valign="top">
      <td headers="studyInfoColTitle" nowrap="nowrap">Study Type:</td>
      <td headers="studyInfoColData" style="padding-left:1em">
        Interventional
                      </td>
    </tr>
            <tr valign="top">
      <td headers="studyInfoColTitle" nowrap="nowrap">Study Design:</td>
      <td headers="studyInfoColData" style="padding-left:1em">Allocation:&nbsp;Randomized<br>Intervention&nbsp;Model:&nbsp;Parallel&nbsp;Assignment<br>Masking:&nbsp;Double&nbsp;Blind&nbsp;(Subject,&nbsp;Investigator)<br>Primary&nbsp;Purpose:&nbsp;Prevention</td>
    </tr>
                <tr valign="top">
      <td headers="studyInfoColTitle" style="padding-top:2ex" nowrap="nowrap">Official Title:</td>
      <td headers="studyInfoColData" style="padding-left:1em; padding-top:2ex">Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial</td>
    </tr>
      </tbody></table>

    <!-- NLM links -->
  <br>
  <div class="header3">Resource links provided by NLM:</div>
  <br>
  <div class="indent3">

    <!-- ghr links -->
  <div style="margin-bottom:2ex">
    <a class="study-link" href="http://ghr.nlm.nih.gov/" title="Genetics Home Reference" onclick="openNewWindow('http://ghr.nlm.nih.gov/'); return false">Genetics Home Reference</a> related topics:
            <a class="study-link" style="margin-left:0.5em;" href="https://clinicaltrials.gov/ct2/bye/9QoPWw4lZXcilwpxudhWudNzlXNiZip90dcx5Q1PedcOZ6NGmQ7aeB7EmB1PSQ7GvX76eBUyedhakihzZdJ." title="familial&nbsp;atrial&nbsp;fibrillation at Genetics Home Reference" onclick="openNewWindow('/ct2/bye/9QoPWw4lZXcilwpxudhWudNzlXNiZip90dcx5Q1PedcOZ6NGmQ7aeB7EmB1PSQ7GvX76eBUyedhakihzZdJ.'); return false">familial&nbsp;atrial&nbsp;fibrillation</a>
          </div>
  
    <!-- medline links -->
  <div style="margin-bottom:2ex;">
    <a class="study-link" href="https://www.nlm.nih.gov/medlineplus/" title="MedlinePlus" onclick="openNewWindow('https://www.nlm.nih.gov/medlineplus/'); return false">MedlinePlus</a> related topics:
            <a class="study-link" style="margin-left:0.5em;" href="https://clinicaltrials.gov/ct2/bye/cQoPWwoRrXS9-i-wudNamXNxeQYxUd-BZd7H5dhzu613vi1RZBNaZdcPWQhzudNHSwSxlihLv." title="Blood&nbsp;Thinners at MedlinePlus" onclick="openNewWindow('/ct2/bye/cQoPWwoRrXS9-i-wudNamXNxeQYxUd-BZd7H5dhzu613vi1RZBNaZdcPWQhzudNHSwSxlihLv.'); return false">Blood&nbsp;Thinners</a>
                <a class="study-link" style="margin-left:0.5em;" href="https://clinicaltrials.gov/ct2/bye/WQoPWwoRrXS9-i-wudNamXNxeQYxUd-BZd7H5dhzu613vi1RZQhHkwUPkioPkBcvuQoPmdt." title="Heart&nbsp;Attack at MedlinePlus" onclick="openNewWindow('/ct2/bye/WQoPWwoRrXS9-i-wudNamXNxeQYxUd-BZd7H5dhzu613vi1RZQhHkwUPkioPkBcvuQoPmdt.'); return false">Heart&nbsp;Attack</a>
                <a class="study-link" style="margin-left:0.5em;" href="https://clinicaltrials.gov/ct2/bye/cQoPWwoRrXS9-i-wudNamXNxeQYxUd-BZd7H5dhzu613vi1RZQhHkwUP5Q1gzB1gzwSxlihLv." title="Heart&nbsp;Diseases at MedlinePlus" onclick="openNewWindow('/ct2/bye/cQoPWwoRrXS9-i-wudNamXNxeQYxUd-BZd7H5dhzu613vi1RZQhHkwUP5Q1gzB1gzwSxlihLv.'); return false">Heart&nbsp;Diseases</a>
          </div>
  
    <!-- SIS links -->
  <div style="margin-bottom:2ex;">
    <a class="study-link" href="http://druginfo.nlm.nih.gov/drugportal/drugportal.jsp" title="Drug Information Portal" onclick="openNewWindow('http://druginfo.nlm.nih.gov/drugportal/drugportal.jsp'); return false">Drug Information</a> available for:
            <a class="study-link" style="margin-left:0.5em;" href="https://clinicaltrials.gov/ct2/bye/tQoPWw4lZXcPSi7iedN6ZXNxvdDxuQ7Ju6c9cXcPSi7iEd-yWB7EZ6o35Q1yzB-VuQUgEscxkd789V1gEQ1yedJ." title="Aspirin at Drug Information Portal" onclick="openNewWindow('/ct2/bye/tQoPWw4lZXcPSi7iedN6ZXNxvdDxuQ7Ju6c9cXcPSi7iEd-yWB7EZ6o35Q1yzB-VuQUgEscxkd789V1gEQ1yedJ.'); return false">Aspirin</a>
                <a class="study-link" style="margin-left:0.5em;" href="https://clinicaltrials.gov/ct2/bye/3QoPWw4lZXcPSi7iedN6ZXNxvdDxuQ7Ju6c9cXcPSi7iEd-yWB7EZ6o35Q1yzB-VuQUgEscxkd789HcGS6NGSQ7O." title="Warfarin at Drug Information Portal" onclick="openNewWindow('/ct2/bye/3QoPWw4lZXcPSi7iedN6ZXNxvdDxuQ7Ju6c9cXcPSi7iEd-yWB7EZ6o35Q1yzB-VuQUgEscxkd789HcGS6NGSQ7O.'); return false">Warfarin</a>
                <a class="study-link" style="margin-left:0.5em;" href="https://clinicaltrials.gov/ct2/bye/nQoPWw4lZXcPSi7iedN6ZXNxvdDxuQ7Ju6c9cXcPSi7iEd-yWB7EZ6o35Q1yzB-VuQUgEscxkd789HcGS6NGSQ7Ofwc95Q1Hm." title="Warfarin&nbsp;sodium at Drug Information Portal" onclick="openNewWindow('/ct2/bye/nQoPWw4lZXcPSi7iedN6ZXNxvdDxuQ7Ju6c9cXcPSi7iEd-yWB7EZ6o35Q1yzB-VuQUgEscxkd789HcGS6NGSQ7Ofwc95Q1Hm.'); return false">Warfarin&nbsp;sodium</a>
          </div>
  
  
  <a class="study-link" href="https://clinicaltrials.gov/ct2/info/fdalinks" title="Show FDA resources page" onclick="openNewWindow('/ct2/info/fdalinks'); return false">U.S. FDA Resources</a>


  
  <br>
  
  </div>
  
    <!-- more details -->
  <br>
  <div class="header3">Further study details as provided by Columbia University:</div>
  <br>
  <div class="indent3">

        <!-- primary outcomes -->
    <div class="body3">Primary Outcome Measures:
      <ul style="margin-top:1ex; margin-bottom:1ex;">
            <li class="color-bullet" style="margin-top:0.7ex;"><span class="li-content">Event
 Rate Per 100 Patient Years for Composite Endpoint of Ischemic Stroke, 
Intracerebral Hemorrhage, or Death [&nbsp;Time&nbsp;Frame:&nbsp;From 
date of randomization until the date of the first to occur of ischemic 
stroke, intracerebral hemorrhage, or death, up to 6 years&nbsp;] 
[&nbsp;Designated&nbsp;as&nbsp;safety&nbsp;issue:&nbsp;Yes&nbsp;]<div class="indent2" style="margin-top:1ex;">The
 time, in years, from randomization to the first to occur of ischemic 
stroke, intracerebral hemorrhage, or death, up to a maximum of 6 years. 
Event rate per 100 patient years = 100*(number of subjects with 
event)/patient-years of follow-up. Patient years of follow-up = sum(date
 of conclusion of follow-up - date of randomization + 1) of all 
randomized patients / 365.25.</div><br>
            </span></li></ul>
    </div>
    <br>
    
        <!-- secondary outcomes -->
    <div class="body3">Secondary Outcome Measures:
      <ul style="margin-top:1ex; margin-bottom:1ex;">
            <li class="color-bullet" style="margin-top:0.7ex;"><span class="li-content">Event Rate Per 100 Patient-years for Composite Endpoint of Hospitalization for Heart Failure, <span class="hit_syn">Myocardial Infarction</span>,
 Ischemic Stroke, Intracerebral Hemorrhage, or Death. 
[&nbsp;Time&nbsp;Frame:&nbsp;From randomization to the first to occur of
 hospitalization for heart failure, myocardial infarction, ischemic 
stroke, intracerebral hemorrhage, or death, up to a maximum of 6 
years.&nbsp;] 
[&nbsp;Designated&nbsp;as&nbsp;safety&nbsp;issue:&nbsp;Yes&nbsp;]<div class="indent2" style="margin-top:1ex;"><p style="margin-top:0ex; margin-bottom:1ex;">The
 time, in years, from date of randomization to the date of the first to 
occur of hospitalization for heart failure, myocardial infarction, 
ischemic stroke, intracerebral hemorrhage, or death, up to 6 years.</p>
    <p style="margin-top:0ex; margin-bottom:1ex;">Event rate per 100 
patient years = 100*(number of subjects with event)/patient-years of 
follow-up. Patient years of follow-up = sum(date of conclusion of 
follow-up - date of randomization + 1) of all randomized patients / 
365.25.</p></div><br>
            </span></li></ul>
    </div>
    <br>
    
        <!-- other outcomes -->
    <div class="body3">Other Outcome Measures:
      <ul style="margin-top:1ex; margin-bottom:1ex;">
            <li class="color-bullet" style="margin-top:0.7ex;"><span class="li-content">Event
 Rate Per 100 Patient-years for Ischemic Stroke 
[&nbsp;Time&nbsp;Frame:&nbsp;From date of randomization to date of 
ischemic stroke component of primary composite outcome, up to 6 
years&nbsp;] 
[&nbsp;Designated&nbsp;as&nbsp;safety&nbsp;issue:&nbsp;Yes&nbsp;]<div class="indent2" style="margin-top:1ex;">Time,
 in years, from date of randomization to date of ischemic stroke 
component of primary composite outcome, up to 6 years. Event rate per 
100 patient years = 100*(number of subjects with ischemic 
stroke)/patient-years of follow-up. Patient years of follow-up = 
sum(date of conclusion of follow-up - date of randomization + 1) of all 
randomized patients / 365.25.</div><br>
            </span></li><li class="color-bullet" style="margin-top:0.7ex;"><span class="li-content">Event
 Rate Per 100 Patient-years for Intracerebral Hemorrhage 
[&nbsp;Time&nbsp;Frame:&nbsp;From date of randomization to date of 
intracerebral hemorrhage component of primary composite outcome, up to 6
 years&nbsp;] 
[&nbsp;Designated&nbsp;as&nbsp;safety&nbsp;issue:&nbsp;Yes&nbsp;]<div class="indent2" style="margin-top:1ex;">Time,
 in years, from date of randomization to date of intracerebral 
hemorrhage component of primary composite outcome. Event rate per 100 
patient years = 100*(number of subjects with intracerebral 
hemorrhage)/patient-years of follow-up. Patient years of follow-up = 
sum(date of conclusion of follow-up - date of randomization + 1) of all 
randomized patients / 365.25.</div><br>
            </span></li><li class="color-bullet" style="margin-top:0.7ex;"><span class="li-content">Event
 Rate Per 100 Patient-years for Death [&nbsp;Time&nbsp;Frame:&nbsp;From 
date of randomization to date of death component of primary composite 
outcome, up to 6 years&nbsp;] 
[&nbsp;Designated&nbsp;as&nbsp;safety&nbsp;issue:&nbsp;Yes&nbsp;]<div class="indent2" style="margin-top:1ex;">Time,
 in years, from date of randomization to date of death component of 
primary composite outcome. Event rate per 100 patient years = 
100*(number of subjects who died)/patient-years of follow-up. Patient 
years of follow-up = sum(date of conclusion of follow-up - date of 
randomization + 1) of all randomized patients / 365.25.</div><br>
            </span></li><li class="color-bullet" style="margin-top:0.7ex;"><span class="li-content">Event
 Rate Per 100 Patient Years of Myocardial Infarction Component of 
Secondary Composite Outcome [&nbsp;Time&nbsp;Frame:&nbsp;From date of 
randomization to date of myocardial infarction component of secondary 
composite outcome, up to 6 years&nbsp;] 
[&nbsp;Designated&nbsp;as&nbsp;safety&nbsp;issue:&nbsp;Yes&nbsp;]<div class="indent2" style="margin-top:1ex;">Time,
 in years, from date of randomization to date of myocardial infarction, 
up to 6 years. Includes only myocardial infarctions that occurred during
 follow-up, before any heart failure hospitalization. Event rate per 100
 patient years = 100*(number of subjects with myocardial 
infarction)/patient-years of follow-up. Patient years of follow-up = 
sum(date of conclusion of follow-up - date of randomization + 1) of all 
randomized patients / 365.25.</div><br>
            </span></li><li class="color-bullet" style="margin-top:0.7ex;"><span class="li-content">Event
 Rate Per 100 Patient Years of Heart Failure Hospitalization Component 
of Secondary Composite Outcome. [&nbsp;Time&nbsp;Frame:&nbsp;From date 
of randomization to date of heart failure hospitalization component of 
secondary composite outcome, up to 6 years&nbsp;] 
[&nbsp;Designated&nbsp;as&nbsp;safety&nbsp;issue:&nbsp;Yes&nbsp;]<div class="indent2" style="margin-top:1ex;">Time,
 in years, from date of randomization to date of heart failure 
hospitalization, up to 6 years. Includes hospitalizations for heart 
failure during follow-up that were not preceded by myocardial 
infarction. Event rate per 100 patient years = 100*(number of subjects 
with heart failure hospitalization)/patient-years of follow-up. Patient 
years of follow-up = sum(date of conclusion of follow-up - date of 
randomization + 1) of all randomized patients / 365.25.</div><br>
            </span></li><li class="color-bullet" style="margin-top:0.7ex;"><span class="li-content">Event
 Rate Per 100 Patient Years of Ischemic Stroke Component of Secondary 
Composite Outcome [&nbsp;Time&nbsp;Frame:&nbsp;From date of 
randomization to date of ischemic stroke component of secondary 
composite outcome, up to 6 years&nbsp;] 
[&nbsp;Designated&nbsp;as&nbsp;safety&nbsp;issue:&nbsp;Yes&nbsp;]<div class="indent2" style="margin-top:1ex;">Ischemic
 stroke component of secondary composite endpoint. Includes only 
ischemic strokes that were not preceded by a myocardial infarction or 
heart failure hospitalization. The number of ischemic strokes that are 
components of the secondary outcome does not therefore match the number 
of ischemic strokes that are components of the primary outcome. Event 
rate per 100 patient years = 100*(number of subjects with ischemic 
stroke)/patient-years of follow-up. Patient years of follow-up = 
sum(date of conclusion of follow-up - date of randomization + 1)of all 
randomized patients / 365.25.</div><br>
            </span></li><li class="color-bullet" style="margin-top:0.7ex;"><span class="li-content">Event
 Rate Per 100 Patient Years of Intracerebral Hemorrhage Component of 
Secondary Composite Outcome [&nbsp;Time&nbsp;Frame:&nbsp;From date of 
randomization to date of intracerebral hemorrhage component of secondary
 composite outcome, up to 6 years&nbsp;] 
[&nbsp;Designated&nbsp;as&nbsp;safety&nbsp;issue:&nbsp;Yes&nbsp;]<div class="indent2" style="margin-top:1ex;">Time,
 in years, from date of randomization to date of intracerebral 
hemorrhage component of secondary composite outcome. Includes only 
intracerebral hemorrhages not preceded by myocardial infarction or heart
 failure hospitalization. Event rate per 100 patient years = 100*(number
 of subjects with intracerebral hemorrhage)/patient-years of follow-up. 
Patient years of follow-up = sum(date of conclusion of follow-up - date 
of randomization + 1) of all randomized patients / 365.25.</div><br>
            </span></li><li class="color-bullet" style="margin-top:0.7ex;"><span class="li-content">Event
 Rate Per 100 Patient Years of Death Component of Secondary Composite 
Outcome [&nbsp;Time&nbsp;Frame:&nbsp;From date of randomization to date 
of death component of secondary composite outcome, up to 6 years&nbsp;] 
[&nbsp;Designated&nbsp;as&nbsp;safety&nbsp;issue:&nbsp;Yes&nbsp;]<div class="indent2" style="margin-top:1ex;">Time,
 in years, from randomization to death component of secondary composite 
outcome. This measure counts only deaths that were not preceded by heart
 failure hospitalization, myocardial infarction, ischemic stroke, or 
intracerebral hemorrhage. Event rate per 100 patient years = 100*(number
 of subjects who died)/patient-years of follow-up. Patient years of 
follow-up = sum(date of conclusion of follow-up - date of randomization +
 1) of all randomized patients / 365.25.</div><br>
            </span></li><li class="color-bullet" style="margin-top:0.7ex;"><span class="li-content">Rate
 Per 100 Patient Years of Major Hemorrhage 
[&nbsp;Time&nbsp;Frame:&nbsp;From date of randomization until end of 
scheduled follow-up, up to 6 years&nbsp;] 
[&nbsp;Designated&nbsp;as&nbsp;safety&nbsp;issue:&nbsp;Yes&nbsp;]<div class="indent2" style="margin-top:1ex;">Rate/100
 patient-years of major hemorrhage. Includes all major hemorrhages in 
any patient. Major hemorrhage was defined as intracerebral, epidural, 
subdural, subarachnoid, spinal intramedullary, or retinal hemorrhage; 
any other bleeding causing a decline in the hemoglobin level of more 
than 2 g per deciliter in 48 hours; or bleeding requiring transfusion of
 2 or more units of whole blood, hospitalization, or surgical 
intervention. Event rate per 100 patient years = 100*(number of major 
hemorrhage events)/patient-years of follow-up. Patient years of 
follow-up = sum(date of conclusion of follow-up - date of randomization +
 1) of all randomized patients / 365.25.</div><br>
            </span></li><li class="color-bullet" style="margin-top:0.7ex;"><span class="li-content">Rate
 Per 100 Patient-years of Minor Hemorrhage. 
[&nbsp;Time&nbsp;Frame:&nbsp;From date of randomization until the end of
 scheduled follow-up, up to 6 years&nbsp;] 
[&nbsp;Designated&nbsp;as&nbsp;safety&nbsp;issue:&nbsp;Yes&nbsp;]<div class="indent2" style="margin-top:1ex;">Rate
 per 100 patient years of minor hemorrhage. Includes all minor 
hemorrhages. Minor hemorrhage was defined as any non-major hemorrhage. 
Event rate per 100 patient years = 100*(number of minor hemorrhage 
events)/patient-years of follow-up. Patient years of follow-up = 
sum(date of conclusion of follow-up - date of randomization + 1)of all 
randomized patients / 365.25.</div><br>
            </span></li></ul>
    </div>
    <br>
    
    
    <table summary="Layout table for enrollment information" class="layout_table" style="margin-bottom:3ex;" border="0" cellpadding="0" cellspacing="0">
      <thead>
      <tr>
        <th id="enrollmentInfoTitle" style="display:none"></th>
        <th id="enrollmentInfoData" style="display:none"></th>
      </tr>
      </thead>
            <tbody><tr valign="top">
        <td headers="enrollmentInfoTitle" nowrap="nowrap"> Enrollment:</td>
        <td headers="enrollmentInfoData" style="padding-left:1em">2305</td>
      </tr>
                  <tr valign="top">
        <td headers="enrollmentInfoTitle" nowrap="nowrap"> Study Start Date:</td>
        <td headers="enrollmentInfoData" style="padding-left:1em">October 2002</td>
      </tr>
                  <tr valign="top">
        <td headers="enrollmentInfoTitle" nowrap="nowrap"> Study Completion Date:</td>
        <td headers="enrollmentInfoData" style="padding-left:1em">July 2014</td>
      </tr>
                  <tr valign="top">
        <td headers="enrollmentInfoTitle" nowrap="nowrap"> Primary Completion Date:</td>
        <td headers="enrollmentInfoData" style="padding-left:1em">August 2011 (Final data collection date for primary outcome measure)</td>
      </tr>
          </tbody></table>

        <!-- arms and groups table -->
    <div align="center">
    <table class="data_table" border="1" cellpadding="5" cellspacing="0" width="100%">
      <tbody><tr align="left">
        <th class="header3 pale_banner_color">
          <a class="study-link" href="https://clinicaltrials.gov/ct2/help/arm_group_desc" title="Help on Arm Group field" onclick="openPopupWindow('/ct2/help/arm_group_desc',false); return false;">
             Arms           </a>
        </th>
                <th class="header3 pale_banner_color">
          <a class="study-link" href="https://clinicaltrials.gov/ct2/help/interventions_desc" title="Help on Interventions field" onclick="openPopupWindow('/ct2/help/interventions_desc',false); return false;">
            Assigned Interventions
          </a>
        </th>
              </tr>
            <tr align="left" valign="top">
        <td class="body3">
          Active Comparator: aspirin
<div class="indent2" style="margin-top:0.5ex">Aspirin: 325 mg per day</div>
        </td>
                <td class="body3">
                      Drug: aspirin
<div class="indent2" style="margin-top:0.5ex">325 mg per day</div>
                  </td>
              </tr>
            <tr align="left" valign="top">
        <td class="body3">
          Active Comparator: warfarin
<div class="indent2" style="margin-top:0.5ex">Warfarin: International Normalized Ratio (INR) 2.5-3.0; target INR 2.75</div>
        </td>
                <td class="body3">
                      Drug: Warfarin
<div class="indent2" style="margin-top:0.5ex">INR 2.5-3.0; target INR 2.75</div>
                  </td>
              </tr>
          </tbody></table>
    </div>
    <br>
    
    
    <a name="desc" id="desc"></a>

    
    
        <!-- detailed description -->
    <span class="header3">Detailed Description:</span>
    <div class="body3"><p style="margin-top:0ex; margin-bottom:1ex;">Warfarin
 has proven effective in patients with ischemic heart disease, 
especially in the reduction of stroke, death and re-infarction following
 myocardial infarction, and in the reduction of stroke in atrial 
fibrillation. Warfarin is the most promising unstudied intervention in 
patients with cardiac failure. This randomized, double-blind, 
multi-center study will define optimal antithrombotic therapy for 
patients with cardiac (heart) failure and patients with low ejection 
fraction (EF). EF is the proportion of left ventricular volume emptied 
during systole. It reliably measures left ventricular systolic function.</p>
    <p style="margin-top:0ex; margin-bottom:1ex;">With the rapidly 
increasing numbers of elderly patients with heart failure, this study 
has important public health implications. The study will determine which
 of two commonly used treatments Warfarin, an anticoagulant, or aspirin,
 a drug which affects platelet function is better for preventing death 
and stroke in patients with low ejection fraction.</p></div>
        
  </div>
  
</div>
</div>
  
<!-- eligibility_section -->
<div class="indent1" style="margin-top:3ex; border:1px solid white">
  <img src="Warfarin%20Versus%20Aspirin%20in%20Reduced%20Cardiac%20Ejection%20Fraction%20%28WARCEF%29%20Trial%20-%20Full%20Text%20View%20-%20ClinicalTrials.gov_files/triangle.gif" alt=""><span class="header2">&nbsp; Eligibility</span><br>

  <br>
  <div class="indent2">
    <table summary="Layout table for eligibility information" class="layout_table" border="0" cellpadding="0" cellspacing="0">
      <thead>
      <tr>
        <th id="elgType" style="display:none"></th>
        <th id="elgData" style="display:none"></th>
      </tr>
      </thead>
            <tbody><tr>
        <td headers="elgType" nowrap="nowrap">Ages Eligible for Study: &nbsp; </td>
        <td headers="elgData" style="padding-left:1em">18 Years and older</td>
      </tr>
                  <tr>
        <td headers="elgType" nowrap="nowrap">Genders Eligible for Study: &nbsp; </td>
        <td headers="elgData" style="padding-left:1em">Both</td>
      </tr>
                  <tr>
        <td headers="elgType" nowrap="nowrap">Accepts Healthy Volunteers: &nbsp; </td>
        <td headers="elgData" style="padding-left:1em">No</td>
      </tr>
                </tbody></table>

    
        <div class="header3" style="margin-top:2ex">Criteria</div>
    <div class="indent2"><p style="margin-top:0ex; margin-bottom:1ex;">Inclusion Criteria</p>
    <ul style="margin-top:1ex; margin-bottom:1ex;">
      <li class="color-bullet" style="margin-top:0.7ex;"><span class="li-content">Cardiac
 EF &lt;=35% by radionuclide ventriculography, left ventriculography or 
quantitive echocardiographic measurement or an echocardiographic Wall 
Motion Index of &lt;=1.2, within three months of enrollment. The 
patient's clinical cardiac state at enrollment should be similar to 
their state at the time of the qualifying echocardiogram. The qualifying
 left ventricular function measurement must be obtained at least three 
months after an MI, coronary bypass grafting, PTCA, and at least one 
month after pacemaker insertion. Patients scheduled for mitral valve 
repair should have qualifying echo after surgery.</span></li>
      <li class="color-bullet" style="margin-top:0.7ex;"><span class="li-content">Modified Rankin score &lt;=4.</span></li>
      <li class="color-bullet" style="margin-top:0.7ex;"><span class="li-content">Patient
 must be taking ACE inhibitors. If intolerant of ACE inhibitor, patient 
must be on angiotensin II receptor blockers or hydralazine and nitrates.</span></li>
      <li class="color-bullet" style="margin-top:0.7ex;"><span class="li-content">Patient
 is able to follow an outpatient protocol (requiring monthly blood tests
 and clinic visits every four months for the duration of the study) and 
is available by telephone.</span></li>
      <li class="color-bullet" style="margin-top:0.7ex;"><span class="li-content">Patient
 understands the purpose and requirements of the study, can make 
him/herself understood, and has provided informed consent.</span></li>
      <li class="color-bullet" style="margin-top:0.7ex;"><span class="li-content">Patients with recent stroke or TIA within twelve (12) months will be eligible to be included in the recent stroke (RS) subgroup.</span></li>
      <li class="color-bullet" style="margin-top:0.7ex;"><span class="li-content">Chronic
 CHF patients (NYHA I * IV) admitted to the hospital can be randomized 
prior to discharge if the patient is stable, taking oral medications for
 24 hours and ambulatory at the time of discharge. Stable New York Heart
 Association Class IV patients will be eligible for randomization.</span></li>
    </ul>
    <p style="margin-top:0ex; margin-bottom:1ex;">Exclusion Criteria</p>
    <ul style="margin-top:1ex; margin-bottom:1ex;">
      <li class="color-bullet" style="margin-top:0.7ex;"><span class="li-content">The
 presence of any of the following unequivocal cardiac sources of 
embolism: chronic or paroxysmal AF, mechanical valve, endocarditis, 
intracardiac mobile or pedunculated thrombus, and valvular vegetation.</span></li>
      <li class="color-bullet" style="margin-top:0.7ex;"><span class="li-content">Cyanotic congenital heart disease, Eisenmenger's syndrome.</span></li>
      <li class="color-bullet" style="margin-top:0.7ex;"><span class="li-content">Decompensated heart failure.</span></li>
      <li class="color-bullet" style="margin-top:0.7ex;"><span class="li-content">Cardiac surgery, angioplasty, or MI within the past 3 months prior to randomization.</span></li>
      <li class="color-bullet" style="margin-top:0.7ex;"><span class="li-content">A
 contraindication to the use of either warfarin or aspirin, e.g. active 
peptic ulcer disease, active bleeding diathesis, platelets &lt;100,000*,
 hematocrit &lt;30, INR &gt;1.3 (if not on warfarin), clotting factor 
abnormality that increases the risk of bleeding, alcohol or substance 
abuse, severe gait instability, cerebral hemorrhage, systemic hemorrhage
 within the past year, severe liver impairment (AST &gt;3x normal*, 
cirrhosis), any condition requiring regular use of non-steroidal 
anti-inflammatory agents, allergy to aspirin or warfarin, uncontrolled 
severe hypertension (systolic pressure &gt;180 mm Hg or diastolic 
pressure &gt; 110 mm Hg), positive stool guaiac not attributable to 
hemorrhoids, creatinine &gt;3.0*. *on most recent test done within 30 
days prior to randomization</span></li>
      <li class="color-bullet" style="margin-top:0.7ex;"><span class="li-content">Patient needs continuing therapy with intravenous heparin or low molecular weight heparin or a specific antiplatelet agent.</span></li>
      <li class="color-bullet" style="margin-top:0.7ex;"><span class="li-content">Dementia or psychiatric or physical problem that prevents the patient from following an outpatient program reliably.</span></li>
      <li class="color-bullet" style="margin-top:0.7ex;"><span class="li-content">Comorbid conditions that may limit survival to less than five years.</span></li>
      <li class="color-bullet" style="margin-top:0.7ex;"><span class="li-content">Pregnancy,
 or female of childbearing potential who is not sterilized or is not 
using a medically accepted form of contraception* (see procedure 
manual). *A pregnancy test is required for all women of childbearing 
age.</span></li>
      <li class="color-bullet" style="margin-top:0.7ex;"><span class="li-content">Enrollment in another study that would conflict with WARCEF.</span></li>
      <li class="color-bullet" style="margin-top:0.7ex;"><span class="li-content">Hospitalization
 for new diagnosis of onset CHF within the past one month or carotid 
endarterectomy or pacemaker insertion within the past one month prior to
 randomization .</span></li>
      <li class="color-bullet" style="margin-top:0.7ex;"><span class="li-content">Person under 18 years of age.</span></li>
    </ul></div>
    
  </div>

</div>

  
<!-- location_section -->
<a name="contacts" id="contacts"></a>
<div class="indent1" style="margin-top:3ex">
<img src="Warfarin%20Versus%20Aspirin%20in%20Reduced%20Cardiac%20Ejection%20Fraction%20%28WARCEF%29%20Trial%20-%20Full%20Text%20View%20-%20ClinicalTrials.gov_files/triangle.gif" alt=""><span class="header2">&nbsp; Contacts and Locations</span><br>

<div class="indent2" style="margin-top:2ex">

Choosing to participate in a study is an important personal decision. 
Talk with your doctor and family members or friends about deciding to 
join a study. 
To learn more about this study, you or your doctor may contact the study
 research staff using the Contacts provided below. 
For general information, see <a href="https://clinicaltrials.gov/ct2/about-studies/learn" target="def_win" onclick="openNewWindow('/ct2/about-studies/learn'); return false;" title="Learn About Clinical Studies - opens new window"><u>Learn About Clinical Studies.</u></a>
<br>
<br>
    Please refer to this study by its ClinicalTrials.gov identifier: NCT00041938<br>
  <br>

  <!-- contacts -->
  
  <!-- locations -->
  <a name="locn" id="locn"></a>

    <a class="header3" title="Show 64 study locations" href="https://clinicaltrials.gov/ct2/show/study/NCT00041938?term=%22Heart+attack%22+AND+%22Los+Angeles%22&amp;rank=5&amp;show_locs=Y#locn">
    <img style="float:left" src="Warfarin%20Versus%20Aspirin%20in%20Reduced%20Cardiac%20Ejection%20Fraction%20%28WARCEF%29%20Trial%20-%20Full%20Text%20View%20-%20ClinicalTrials.gov_files/plus.gif" alt="" border="0"> &nbsp; Show 64 Study Locations
  </a><br>

  
  <!-- sponsors -->
    <div class="header3" style="margin-top:2ex">Sponsors and Collaborators</div>
    <div class="indent2" style="margin-top:1ex">Columbia University</div>
    <div class="indent2" style="margin-top:1ex">National Institute of Neurological Disorders and Stroke (NINDS)</div>
    
  <!-- investigators -->
    <div class="header3" style="margin-top:2ex">Investigators</div>
  <table summary="Layout table for investigator information" class="layout_table indent2" border="0" cellpadding="0" cellspacing="0">
    <thead>
    <tr>
      <th id="role" style="display:none"></th>
      <th id="name" style="display:none"></th>
      <th id="affiliation" style="display:none"></th>
      <th id="address" style="display:none"></th>
    </tr>
    </thead>
        <tbody><tr>
      <td headers="role" style="padding:1ex 1em 0px 0px" nowrap="nowrap">Principal Investigator:</td>
      <td headers="name" style="padding:1ex 1em 0px 0px" nowrap="nowrap">Shunichi Homma, M.D.</td>
            <td headers="affiliation" style="padding:1ex 1em 0px 0px" nowrap="nowrap">Principal
 Cardiologist, Associate Chief, Division of Cardiology, and Director, 
Echocardiography Laboratories Professor of Medicine</td>
                  <td headers="address"></td>
          </tr>
        <tr>
      <td headers="role" style="padding:1ex 1em 0px 0px" nowrap="nowrap">Principal Investigator:</td>
      <td headers="name" style="padding:1ex 1em 0px 0px" nowrap="nowrap">Seamus Thompson, PhD</td>
            <td headers="affiliation" style="padding:1ex 1em 0px 0px" nowrap="nowrap">Statistical PI: Clinical Professor of Biostatistics and Neurology</td>
                  <td headers="address"></td>
          </tr>
      </tbody></table>
  

</div>
</div>

<!-- more_info_section -->
<div class="indent1" style="margin-top:3ex; border:1px solid white">
<img src="Warfarin%20Versus%20Aspirin%20in%20Reduced%20Cardiac%20Ejection%20Fraction%20%28WARCEF%29%20Trial%20-%20Full%20Text%20View%20-%20ClinicalTrials.gov_files/triangle.gif" alt=""><span class="header2">&nbsp; More Information</span>

<div class="indent2">
  <br>


  
    No publications provided  by Columbia University <br>
  <br>
  
    Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
  <div class="indent2">
        <div style="margin-top:2ex">
            <a class="study-link" href="https://clinicaltrials.gov/ct2/bye/rQoPWwoRrXS9-i-wudNgpQDxudhWudNzlXNiZip9Ei7ym67VZR08OgCtWR08A6h9Ei4L3BUgWwNG0it." title="Homma S, Thompson JL, Qian M, Ye S, Di Tullio MR, Lip GY, Mann DL, Sacco RL, Levin B, Pullicino PM, Freudenberger RS, Teerlink JR, Graham S, Mohr JP, Labovitz AJ, Buchsbaum R, Estol CJ, Lok DJ, Ponikowski P, Anker SD; WARCEF Investigators. Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy. Circ Heart Fail. 2015 May;8(3):504-9. doi: 10.1161/CIRCHEARTFAILURE.114.001725. Epub 2015 Apr 7." onclick="openNewWindow('/ct2/bye/rQoPWwoRrXS9-i-wudNgpQDxudhWudNzlXNiZip9Ei7ym67VZR08OgCtWR08A6h9Ei4L3BUgWwNG0it.'); return false">Homma
 S, Thompson JL, Qian M, Ye S, Di Tullio MR, Lip GY, Mann DL, Sacco RL, 
Levin B, Pullicino PM, Freudenberger RS, Teerlink JR, Graham S, Mohr JP,
 Labovitz AJ, Buchsbaum R, Estol CJ, Lok DJ, Ponikowski P, Anker SD; 
WARCEF Investigators. Quality of anticoagulation control in preventing 
adverse events in patients with heart failure in sinus rhythm: Warfarin 
versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy. Circ
 Heart Fail. 2015 May;8(3):504-9. doi: 
10.1161/CIRCHEARTFAILURE.114.001725. Epub 2015 Apr 7.</a>
                </div>
        <div style="margin-top:2ex">
            <a class="study-link" href="https://clinicaltrials.gov/ct2/bye/rQoPWwoRrXS9-i-wudNgpQDxudhWudNzlXNiZip9Ei7ym67VZR08WgCBcKCnA6h9Ei4L3BUgWwNG0it." title="Shaffer JA, Thompson JL, Cheng B, Ye S, Lip GY, Mann DL, Sacco RL, Pullicino PM, Freudenberger RS, Graham S, Mohr JP, Labovitz AJ, Estol CJ, Lok DJ, Ponikowski P, Anker SD, Di Tullio MR, Homma S; WARCEF Investigators. Association of quality of life with anticoagulant control in patients with heart failure: the Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) trial. Int J Cardiol. 2014 Dec 15;177(2):715-7." onclick="openNewWindow('/ct2/bye/rQoPWwoRrXS9-i-wudNgpQDxudhWudNzlXNiZip9Ei7ym67VZR08WgCBcKCnA6h9Ei4L3BUgWwNG0it.'); return false">Shaffer
 JA, Thompson JL, Cheng B, Ye S, Lip GY, Mann DL, Sacco RL, Pullicino 
PM, Freudenberger RS, Graham S, Mohr JP, Labovitz AJ, Estol CJ, Lok DJ, 
Ponikowski P, Anker SD, Di Tullio MR, Homma S; WARCEF Investigators. 
Association of quality of life with anticoagulant control in patients 
with heart failure: the Warfarin and Aspirin in Reduced Cardiac Ejection
 Fraction (WARCEF) trial. Int J Cardiol. 2014 Dec 15;177(2):715-7.</a>
                </div>
        <div style="margin-top:2ex">
            <a class="study-link" href="https://clinicaltrials.gov/ct2/bye/rQoPWwoRrXS9-i-wudNgpQDxudhWudNzlXNiZip9Ei7ym67VZR0ROK4jOg4BA6h9Ei4L3BUgWwNG0it." title="Homma S, Thompson JL, Sanford AR, Mann DL, Sacco RL, Levin B, Pullicino PM, Freudenberger RS, Teerlink JR, Graham S, Mohr JP, Massie BM, Labovitz AJ, Di Tullio MR, Gabriel AP, Lip GY, Estol CJ, Lok DJ, Ponikowski P, Anker SD; WARCEF Investigators. Benefit of warfarin compared with aspirin in patients with heart failure in sinus rhythm: a subgroup analysis of WARCEF, a randomized controlled trial. Circ Heart Fail. 2013 Sep 1;6(5):988-97. doi: 10.1161/CIRCHEARTFAILURE.113.000372. Epub 2013 Jul 23." onclick="openNewWindow('/ct2/bye/rQoPWwoRrXS9-i-wudNgpQDxudhWudNzlXNiZip9Ei7ym67VZR0ROK4jOg4BA6h9Ei4L3BUgWwNG0it.'); return false">Homma
 S, Thompson JL, Sanford AR, Mann DL, Sacco RL, Levin B, Pullicino PM, 
Freudenberger RS, Teerlink JR, Graham S, Mohr JP, Massie BM, Labovitz 
AJ, Di Tullio MR, Gabriel AP, Lip GY, Estol CJ, Lok DJ, Ponikowski P, 
Anker SD; WARCEF Investigators. Benefit of warfarin compared with 
aspirin in patients with heart failure in sinus rhythm: a subgroup 
analysis of WARCEF, a randomized controlled trial. Circ Heart Fail. 2013
 Sep 1;6(5):988-97. doi: 10.1161/CIRCHEARTFAILURE.113.000372. Epub 2013 
Jul 23.</a>
                </div>
        <div style="margin-top:2ex">
            <a class="study-link" href="https://clinicaltrials.gov/ct2/bye/rQoPWwoRrXS9-i-wudNgpQDxudhWudNzlXNiZip9Ei7ym67VZR0nLgCjaR48A6h9Ei4L3BUgWwNG0it." title="Homma S, Thompson JL, Pullicino PM, Levin B, Freudenberger RS, Teerlink JR, Ammon SE, Graham S, Sacco RL, Mann DL, Mohr JP, Massie BM, Labovitz AJ, Anker SD, Lok DJ, Ponikowski P, Estol CJ, Lip GY, Di Tullio MR, Sanford AR, Mejia V, Gabriel AP, del Valle ML, Buchsbaum R; WARCEF Investigators. Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med. 2012 May 17;366(20):1859-69. doi: 10.1056/NEJMoa1202299. Epub 2012 May 2." onclick="openNewWindow('/ct2/bye/rQoPWwoRrXS9-i-wudNgpQDxudhWudNzlXNiZip9Ei7ym67VZR0nLgCjaR48A6h9Ei4L3BUgWwNG0it.'); return false">Homma
 S, Thompson JL, Pullicino PM, Levin B, Freudenberger RS, Teerlink JR, 
Ammon SE, Graham S, Sacco RL, Mann DL, Mohr JP, Massie BM, Labovitz AJ, 
Anker SD, Lok DJ, Ponikowski P, Estol CJ, Lip GY, Di Tullio MR, Sanford 
AR, Mejia V, Gabriel AP, del Valle ML, Buchsbaum R; WARCEF 
Investigators. Warfarin and aspirin in patients with heart failure and 
sinus rhythm. N Engl J Med. 2012 May 17;366(20):1859-69. doi: 
10.1056/NEJMoa1202299. Epub 2012 May 2.</a>
                </div>
      </div>
  <br>
  
  
  <table summary="Layout table for additional information" class="layout_table" style="margin-top:1ex" border="0" cellpadding="0" cellspacing="0">
    <thead>
    <tr>
      <th id="colTitle" style="display:none"></th>
      <th id="colData" style="display:none"></th>
    </tr>
    </thead>
        <tbody><tr valign="top">
      <td headers="colTitle" nowrap="nowrap">Responsible Party:</td>
      <td headers="colData" style="padding-left:1em">Shunichi Homma, 
Margaret Milliken Hatch Professor of Medicine at the New 
York-Presbyterian Hospital at the Columbia University Medical Center (In
 Biomedical Engineering), Columbia University</td>
    </tr>
        <tr valign="top">
      <td headers="colTitle" nowrap="nowrap">ClinicalTrials.gov Identifier:</td>
      <td headers="colData" style="padding-left:1em">
        <a class="study-link" title="Current version of study NCT00041938 on ClinicalTrials.gov" href="https://clinicaltrials.gov/show/NCT00041938">NCT00041938</a> &nbsp; &nbsp;
        <a class="study-link" href="https://clinicaltrials.gov/ct2/archive/NCT00041938" title="Historical versions of study NCT00041938 on ClinicalTrials.gov Archive Site" onclick="openNewWindow('/ct2/archive/NCT00041938'); return false;">History of Changes</a>
      </td>
    </tr>
            <tr valign="top">
      <td headers="colTitle" nowrap="nowrap">Other Study ID Numbers:</td>
      <td headers="colData" style="padding-left:1em">AAAC1093, U01NS039143-01, R01NS39154, CRC</td>
    </tr>
            <tr valign="top">
      <td headers="colTitle" nowrap="nowrap">Study First Received:</td>
      <td headers="colData" style="padding-left:1em">July 19, 2002</td>
    </tr>
            <tr valign="top">
      <td headers="colTitle" nowrap="nowrap">Results First Received:</td>
      <td headers="colData" style="padding-left:1em">January 3, 2013</td>
    </tr>
            <tr valign="top">
      <td headers="colTitle" nowrap="nowrap">Last Updated:</td>
      <td headers="colData" style="padding-left:1em">August 29, 2014</td>
    </tr>
            <tr valign="top">
      <td headers="colTitle" nowrap="nowrap">Health Authority:</td>
      <td headers="colData" style="padding-left:1em">United States: Federal Government<br></td>
    </tr>
      </tbody></table>

  
  <!-- keywords -->
    <br>
  Keywords provided by Columbia University:
  <div class="indent3">
    <table summary="Layout table for keywords" class="layout_table" border="0" cellpadding="0" cellspacing="0" width="100%">
      <thead>
      <tr>
        <th id="keywordCol1" style="display:none"></th>
        <th id="keywordCol2" style="display:none"></th>
      </tr>
      </thead>
      <tbody><tr valign="top">
        <td headers="keywordCol1" width="50%">
                    heart disease<br>
                    stroke<br>
                    ischemic heart disease<br>
                    <span class="hit_syn">myocardial infarction</span><br>
                    atrial fibrillation<br>
                  </td>
                <td headers="keywordCol2" style="padding-left:1em" width="50%">
                    low ejection fraction<br>
                    cardiac failure<br>
                    aspirin<br>
                    Warfarin<br>
                    anticoagulant<br>
                  </td>
              </tr>
    </tbody></table>
  </div>
  
  <!-- mesh terms -->
    <br>
  Additional relevant MeSH terms:
  <div class="indent3">
    <table summary="Layout table for MeSH terms" class="layout_table" border="0" cellpadding="0" cellspacing="0" width="100%">
      <thead>
      <tr>
        <th id="meshTermCol1" style="display:none"></th>
        <th id="meshTermCol2" style="display:none"></th>
      </tr>
      </thead>
      <tbody><tr valign="top">
        <td headers="meshTermCol1" width="50%">
                    <span class="hit_syn">Myocardial Infarction</span><br>
                    Coronary Artery Disease<br>
                    Heart Diseases<br>
                    Infarction<br>
                    Myocardial Ischemia<br>
                    Arterial Occlusive Diseases<br>
                    Arteriosclerosis<br>
                    Cardiovascular Diseases<br>
                    Coronary Disease<br>
                    Ischemia<br>
                    Necrosis<br>
                    Pathologic Processes<br>
                    Vascular Diseases<br>
                    Aspirin<br>
                    Warfarin<br>
                  </td>
                <td headers="meshTermCol1" style="padding-left:1em" width="50%">
                    Analgesics<br>
                    Analgesics, Non-Narcotic<br>
                    Anti-Inflammatory Agents<br>
                    Anti-Inflammatory Agents, Non-Steroidal<br>
                    Anticoagulants<br>
                    Antipyretics<br>
                    Antirheumatic Agents<br>
                    Cardiovascular Agents<br>
                    Central Nervous System Agents<br>
                    Cyclooxygenase Inhibitors<br>
                    Enzyme Inhibitors<br>
                    Fibrin Modulating Agents<br>
                    Fibrinolytic Agents<br>
                    Hematologic Agents<br>
                    Molecular Mechanisms of Pharmacological Action<br>
                  </td>
              </tr>
    </tbody></table>
  </div>
  
  
  <br>

    <span class="body3">ClinicalTrials.gov processed this record on September 26, 2015</span><br>
  
  <br>

</div>
</div>


<div id="to-top"><a href="#wrapper">To Top</a></div>

	<div style="clear:both;"></div>
</div>  

      <div id="for-footer">
        <ul class="horz-list">
            <li><a href="https://clinicaltrials.gov/ct2/help/for-patient">For Patients and Families</a></li>
            <li><a href="https://clinicaltrials.gov/ct2/help/for-researcher">For Researchers</a></li>
            <li><a href="https://clinicaltrials.gov/ct2/help/for-manager">For Study Record Managers</a></li>
        </ul>
    </div>

<div id="footer-menu">
    <ul class="horz-list">
		<li><a href="https://clinicaltrials.gov/ct2/home" style="white-space:nowrap">Home</a></li>
		<li><a href="https://clinicaltrials.gov/ct2/resources/rss" style="white-space:nowrap">RSS Feeds</a></li>
		<li><a href="https://clinicaltrials.gov/ct2/sitemap" style="white-space:nowrap">Site Map</a></li>
		<li><a href="https://clinicaltrials.gov/ct2/about-site/terms-conditions" style="white-space:nowrap">Terms and Conditions</a></li>
		<li><a href="https://clinicaltrials.gov/ct2/about-site/disclaimer#" style="white-space:nowrap">Disclaimer</a></li>
		<li><a href="https://clinicaltrials.gov/ct2/helpdesk?hd_url=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2Fstudy%2FNCT00041938%3Fterm%3D%2522Heart%2Battack%2522%2BAND%2B%2522Los%2BAngeles%2522%26rank%3D5" style="white-space:nowrap">Contact NLM Help Desk</a></li>
	</ul>
</div>

</div>  
<div id="fine-print">
	<ul class="horz-list">
		<li><a title="NLM copyright information - opens new window" href="https://www.nlm.nih.gov/copyright.html" onclick="openNewWindow('https://www.nlm.nih.gov/copyright.html'); return false">Copyright</a></li>
		<li><a title="NLM privacy policy - opens new window" href="https://www.nlm.nih.gov/privacy.html" onclick="openNewWindow('https://www.nlm.nih.gov/privacy.html'); return false">Privacy</a></li>
		<li><a title="NLM accessibility - opens new window" href="https://www.nlm.nih.gov/accessibility.html" onclick="openNewWindow('https://www.nlm.nih.gov/accessibility.html'); return false">Accessibility</a></li>
		<li><a title="NLM viewers and players - opens new window" href="https://www.nlm.nih.gov/plugins.html" onclick="openNewWindow('https://www.nlm.nih.gov/plugins.html'); return false">Viewers &amp; Players</a></li>
		<li><a title="NIH Freedom of Information Act office - opens new window" href="http://www.nih.gov/icd/od/foia/index.htm" onclick="openNewWindow('http://www.nih.gov/icd/od/foia/index.htm'); return false">Freedom of Information Act</a></li>
		<li class="last-item"><a title="USA.gov - opens new window" href="http://www.usa.gov/" onclick="openNewWindow('http://www.usa.gov/'); return false">USA.gov</a></li>
	</ul>
    <ul class="horz-list">
       <li><a title="U.S. National Library of Medicine - opens new window" href="https://www.nlm.nih.gov/" onclick="openNewWindow('https://www.nlm.nih.gov/'); return false">U.S. National Library of Medicine</a></li>
       <li><a title="U.S. National Institutes of Health - opens new window" href="http://www.nih.gov/" onclick="openNewWindow('http://www.nih.gov/'); return false">U.S. National Institutes of Health</a></li>
       <li class="last-item"><a title="U.S. Department of Health and Human Services - opens new window" href="https://www.hhs.gov/" onclick="openNewWindow('https://www.hhs.gov/'); return false">
            U.S. Department of Health and Human Services</a></li>
    </ul>
</div>

    <script type="text/javascript" src="Warfarin%20Versus%20Aspirin%20in%20Reduced%20Cardiac%20Ejection%20Fraction%20%28WARCEF%29%20Trial%20-%20Full%20Text%20View%20-%20ClinicalTrials.gov_files/pinger.js"></script>



<ul class="print-log"><li></li></ul></body></html>